Iconovo
9.1 SEK -1.52%Be the first to follow this company
Iconovo is a medical technology company. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and carbon monoxide, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and is headquartered in Lund.
Revenue
7.08M
EBIT %
-646.61 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ICO
Daily low / high price
8.44 / 9.1
SEK
Market cap
144.86M SEK
Turnover
345.95K SEK
Volume
39K
Financial calendar
Interim report
2024-07-12
Interim report
2024-10-24
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gerald Engström | 17.2 % | 17.2 % |
Mats Johansson | 7.9 % | 7.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Kommuniké från årsstämma i Iconovo AB den 21 maj 2024
BioStock: Iconovo inleder utveckling av inhalerad fetmabehandling
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools